BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hölscher C. Glucagon-like peptide 1 and glucose-dependent insulinotropic peptide hormones and novel receptor agonists protect synapses in Alzheimer’s and Parkinson’s diseases. Front Synaptic Neurosci 2022;14:955258. [DOI: 10.3389/fnsyn.2022.955258] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Reich N, Hölscher C. The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review. Front Neurosci 2022;16:970925. [DOI: 10.3389/fnins.2022.970925] [Cited by in F6Publishing: 1] [Reference Citation Analysis]